scholarly journals Comorbidity and health services' usage in children with autism spectrum disorder: a nested case–control study

Author(s):  
Yotam Dizitzer ◽  
Gal Meiri ◽  
Hagit Flusser ◽  
Analya Michaelovski ◽  
Ilan Dinstein ◽  
...  

Abstract Aims Children with autism spectrum disorder (ASD) tend to suffer from various medical comorbidities. We studied the comorbidity burden and health services' utilisation of children with ASD to highlight potential aetiologies and to better understand the medical needs of these children. Methods In this nested case–control study, ASD cases and controls – matched by age, sex and ethnicity in a 1:5 ratio – were sampled from all children born between 2009 and 2016 at a tertiary medical centre. Data were obtained from the hospital's electronic database. Comorbid diagnoses were classified according to pathophysiological aetiology and anatomical/systemic classification of disease. Standard univariate and multivariate statistics were used to demonstrate comorbidities and health services' utilisation patterns that are significantly associated with ASD. Results ASD children had higher rates of comorbidities according to both pathophysiological and anatomical/systemic classifications (p < 0.001). The most marked significant differences were observed for: hearing impairments (OR = 4.728; 95% CI 2.207–10.127) and other auricular conditions (OR = 5.040; 95% CI 1.759–14.438); neurological (OR = 8.198; 95% CI 5.690–11.813) and ophthalmological (OR = 3.381; 95% CI 1.617–7.068) conditions; and ADD/ADHD (OR = 3.246; 95% CI 1.811–5.818). A subgroup analysis revealed a more profound case–control difference in anaemia rates among girls than in boys (OR = 3.25; 95% CI 1.04–10.19 v. OR = 0.74; 95% CI 0.33–1.64 respectively) and an opposite trend (larger differences in males than in females in cardiovascular diseases (OR = 1.99; 95% CI 1.23–3.23 v. OR = 0.76; 95% CI 0.17–3.45, respectively)). In addition, larger case–control differences were seen among Bedouin children than in Jewish children in a number of medical comorbidities (Breslow–Day test for homogeneity of odds ratio p-value <0.05). Finally, we found that children with ASD tended to be referred to the emergency department and to be admitted to the hospital more frequently than children without ASD, even after adjusting for their comorbidity burden (aOR = 1.28; 95% CI 1.08–1.50 and aOR = 1.28; 95% CI 1.11–1.47 for >1 referrals and admissions per year, respectively). Conclusions The findings of this study contribute to the overall understanding of comorbid conditions and health services' utilisation for children with ASD. The higher prevalences of comorbidities and healthcare services' utilisation for children with ASD highlight the additional medical burden associated with this condition.

2017 ◽  
Vol 30 ◽  
pp. 200-201 ◽  
Author(s):  
Salah Basheer ◽  
Archana Natarajan ◽  
Therese van Amelsvoort ◽  
Manjunatha M. Venkataswamy ◽  
Vasanthapuram Ravi ◽  
...  

2018 ◽  
Vol 50 ◽  
pp. 51-59 ◽  
Author(s):  
Kelly Barnhill ◽  
Alan Gutierrez ◽  
Maliki Ghossainy ◽  
Zabin Marediya ◽  
Morgan Devlin ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Nitzan Abelson ◽  
Gal Meiri ◽  
Shirley Solomon ◽  
Hagit Flusser ◽  
Analya Michaelovski ◽  
...  

Background: Multiple prenatal factors have been associated with autism spectrum disorder (ASD) risk. However, current data about the association between antimicrobial use during pregnancy and ASD is limited.Methods: A nested matched case-control study of children with ASD (cases), and children without ASD or other psychiatric or genetic disorders (controls). We compared the use of antimicrobial therapy during the 3 months before conception or during pregnancy between mothers of cases and controls and used multivariate conditional logistic regression models to assess the independent association between maternal use of antimicrobials during pregnancy and the risk of ASD in their offspring.Results: More than half of the mothers in the study (54.1%) used antimicrobial drugs during the 3 months before conception or during pregnancy. Rates of antimicrobial use were lower for mothers of children with ASD compared to mothers of controls (49.0 vs. 55.1%, respectively; p = 0.02), especially during the third trimester of pregnancy (18.8 vs. 22.9%, respectively; p = 0.03), and for the use of penicillins (15.7 vs. 19.7%, respectively; p = 0.06). These case–control differences suggest that antimicrobial administration during pregnancy was associated with a reduced risk of ASD in the offspring (aOR = 0.75, 95% CI = 0.61–0.92). Interestingly, this association was seen only among Jewish but not for the Bedouin mothers (aOR = 0.62, 95% CI = 0.48–0.79 and aOR = 1.21, 95% CI = 0.82–1.79).Conclusions: The reduced risk of ASD associated with prenatal antimicrobials use only in the Jewish population suggest the involvement of other ethnic differences in healthcare services utilization in this association.


2018 ◽  
Vol 94 ◽  
pp. 162-167 ◽  
Author(s):  
Salah Basheer ◽  
Manjunatha M. Venkataswamy ◽  
Rita Christopher ◽  
Therese Van Amelsvoort ◽  
Shoba Srinath ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document